Journal Article Summary
The article investigates the potential link between proton pump inhibitors (PPIs) and osteoporosis-related adverse events. PPIs are commonly prescribed medications for various acid-related conditions, but their long-term effects on bone health remain uncertain. Understanding this relationship is crucial, especially as many patients use PPIs for extended periods, which may increase their risk of developing osteoporosis and related complications.
The researchers analyzed data from the FDA's Adverse Event Reporting System, covering reports from 2004 to 2024. They focused on five widely used PPIs: esomeprazole, omeprazole, lansoprazole, pantoprazole, and rabeprazole. The findings revealed that esomeprazole and omeprazole were associated with a higher incidence of osteoporosis-related events, particularly among women and older adults. The study also noted that the risk of these adverse events increased over time for esomeprazole, while omeprazole did not show a consistent pattern.
However, the study has limitations, including reliance on a database that may contain reporting biases and the inability to establish direct causal relationships. Patients should discuss their use of PPIs with healthcare professionals, especially if they have concerns about bone health or are at risk for osteoporosis. It is essential for patients to weigh the benefits and risks of long-term PPI use and consider monitoring strategies or preventive measures for osteoporosis if necessary.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Di Jingkai, Yang Nan, Zhao Yicong, Chen Shuai, Guo Zijian, He Dongdong, Xiang Chuan. Evaluating the risk of osteoporosis-related adverse events with proton pump inhibitors: a pharmacovigilance study. Frontiers in Pharmacology 2025. DOI: 10.3389/fphar.2025.1582908. PMID: 40717976. PMCID: PMC12290295.
Featured Pill Pals Product
Omeprazole 20 mg Capsules --- 30 Count --- Generic for Prilosec --- Xiromed Pharma
Omeprazole 20 mg Capsules — 30 Count — Generic for Prilosec — Xiromed Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
